T1	CHEM 16 25	lidocaína
#1	AnnotatorNotes T1	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T2	PROC 45 92	biopsias transrectales ecodirigidas de próstata
#2	AnnotatorNotes T2	C2316669; Transrectal biopsy of prostate using ultrasound guidance; Diagnostic Procedure
T3	CHEM 493 502	Xylocaina
#3	AnnotatorNotes T3	C0699094; Xylocaine; Organic Chemical · Pharmacologic Substance
T4	ANAT 84 92	próstata
#4	AnnotatorNotes T4	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T5	CHEM 555 565	lubricante
#5	AnnotatorNotes T5	C4055972; Lubricant Gel/Jelly ; Biomedical or Dental Material
T6	DISO 153 162	molestias
#6	AnnotatorNotes T6	C2364135; Discomfort; Sign or Symptom
T7	PROC 178 186	biopsias
#7	AnnotatorNotes T7	C0005558; Biopsy; Diagnostic Procedure
T8	PROC 189 210	evaluamos la eficacia
#8	AnnotatorNotes T8	C1707887; Efficacy Study; Research Activity
T9	CHEM 222 231	lidocaína
#9	AnnotatorNotes T9	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T10	PROC 281 328	biopsias transrectales de próstata ecodirigidas
T11	ANAT 307 315	próstata
#10	AnnotatorNotes T11	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T12	PROC 623 636	procedimiento
#11	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T13	DISO 352 377	adenocarcinoma prostático
#12	AnnotatorNotes T13	C0007112; Adenocarcinoma of prostate; Neoplastic Process
T14	PROC 400 428	incluidos de forma aleatoria
#13	AnnotatorNotes T14	C0034656; Randomization; Research Activity
T15	CHEM 475 484	lidocaína
#14	AnnotatorNotes T15	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T16	PROC 546 553	placebo
#15	AnnotatorNotes T16	C0032042; Placebos; Therapeutic or Preventive Procedure
T17	PROC 570 579	anestesia
#16	AnnotatorNotes T17	C0002903; Anesthesia procedures; Therapeutic or Preventive Procedure
T18	DISO 728 737	molestias
#17	AnnotatorNotes T18	C2364135; Discomfort; Sign or Symptom
T19	DISO 835 844	molestias
#18	AnnotatorNotes T19	C2364135; Discomfort; Sign or Symptom
T20	PROC 1092 1108	anestesia tópica
#19	AnnotatorNotes T20	C0472473; Topical local anesthetic; Therapeutic or Preventive Procedure
T21	CHEM 1178 1181	PSA
#20	AnnotatorNotes T21	C0138741; Prostate-Specific Antigen; Amino Acid, Peptide, or Protein · Enzyme · Immunologic Factor
T22	PROC 1183 1191	biopsias
#21	AnnotatorNotes T22	C0005558; Biopsy; Diagnostic Procedure
T23	CHEM 1227 1236	lidocaína
#22	AnnotatorNotes T23	C0023660; lidocaine; Organic Chemical · Pharmacologic Substance
T24	DISO 1293 1302	molestias
#23	AnnotatorNotes T24	C2364135; Discomfort; Sign or Symptom
T25	DISO 165 170	dolor
#24	AnnotatorNotes T25	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T26	ANAT 367 377	prostático
#25	AnnotatorNotes T26	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T27	CHEM 773 782	Xylocaína
#26	AnnotatorNotes T27	C0699094; Xylocaine; Organic Chemical · Pharmacologic Substance
T28	DISO 672 677	dolor
#27	AnnotatorNotes T28	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T29	DISO 695 700	dolor
#28	AnnotatorNotes T29	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T30	DISO 716 721	dolor
#29	AnnotatorNotes T30	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T31	DISO 827 832	dolor
#30	AnnotatorNotes T31	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T32	DISO 1053 1058	dolor
#31	AnnotatorNotes T32	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T33	PROC 1169 1181	nivel de PSA
#32	AnnotatorNotes T33	C0201544; Prostate specific antigen measurement; Laboratory Procedure
T34	DISO 1305 1310	dolor
#33	AnnotatorNotes T34	C0030193; Pain; Sign or Symptom | C0234238; Ache; Sign or Symptom
T35	Form 9 12	gel
#34	AnnotatorNotes T35	C0017243; Gel; Biomedical or Dental Material
T36	Form 215 218	gel
#35	AnnotatorNotes T36	C0017243; Gel; Biomedical or Dental Material
T37	Spec_cue 340 351	sospecha de
T38	LIVB 383 392	pacientes
#36	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	Form 468 471	gel
#37	AnnotatorNotes T39	C0017243; Gel; Biomedical or Dental Material
T40	Dose 486 491	20 mg
T41	Neg_cue 566 569	sin
T42	Duration 600 612	diez minutos
T43	Neg_cue 692 694	no
T44	LIVB 750 759	pacientes
#38	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T47	Form 1073 1076	gel
#39	AnnotatorNotes T47	C0017243; Gel; Biomedical or Dental Material
T48	Route 1102 1108	tópica
#40	AnnotatorNotes T48	C1522168; Topical Route of Drug Administration; Functional Concept
T50	Form 1220 1223	gel
#41	AnnotatorNotes T50	C0017243; Gel; Biomedical or Dental Material
T51	Route 26 37	intrarectal
#42	AnnotatorNotes T51	C1527425; Rectal Route of Drug Administration; Functional Concept
T52	Route 232 243	intrarectal
#43	AnnotatorNotes T52	C1527425; Rectal Route of Drug Administration; Functional Concept
T53	Route 506 517	intrarectal
#44	AnnotatorNotes T53	C1527425; Rectal Route of Drug Administration; Functional Concept
T45	Route 1077 1088	intrarectal
#45	AnnotatorNotes T45	C1527425; Rectal Route of Drug Administration; Functional Concept
A1	Assertion T13 Speculated
A2	Assertion T17 Negated
A3	Assertion T29 Negated
A4	Status T22 History_of
R1	Negation Arg1:T41 Arg2:T17	
R2	Negation Arg1:T43 Arg2:T29	
T46	Neg_cue 852 854	no
T49	CONC 875 888	significación
A5	Assertion T49 Negated
#46	AnnotatorNotes T49	C0237881; Statistical Significance; Quantitative Concept
R3	Negation Arg1:T46 Arg2:T49	
T54	CONC 1130 1141	diferencias
A6	Assertion T54 Negated
#47	AnnotatorNotes T54	C1705241; Delta (difference); Quantitative Concept
T55	Neg_cue 1110 1112	No
R4	Negation Arg1:T55 Arg2:T54	
R5	Has_Drug_Form Arg1:T1 Arg2:T35	
R6	Has_Route_or_Mode Arg1:T1 Arg2:T51	
R7	Location_of Arg1:T4 Arg2:T2	
R8	Causes Arg1:T7 Arg2:T25	
R9	Causes Arg1:T7 Arg2:T6	
R10	Has_Drug_Form Arg1:T9 Arg2:T36	
R11	Has_Route_or_Mode Arg1:T9 Arg2:T52	
R12	Location_of Arg1:T11 Arg2:T10	
R13	Speculation Arg1:T37 Arg2:T13	
R14	Location_of Arg1:T26 Arg2:T13	
R15	Experiences Arg1:T38 Arg2:T15	
R16	Before Arg1:T14 Arg2:T15	
R17	Before Arg1:T14 Arg2:T16	
R18	Before Arg1:T14 Arg2:T3	
R19	Has_Route_or_Mode Arg1:T3 Arg2:T53	
R20	Has_Dose_or_Strength Arg1:T3 Arg2:T40	
R21	Has_Drug_Form Arg1:T15 Arg2:T39	
R22	Used_for Arg1:T5 Arg2:T16	
R23	Before Arg1:T15 Arg2:T12	
R24	Before Arg1:T16 Arg2:T12	
R25	Has_Route_or_Mode Arg1:T15 Arg2:T53	
R26	Has_Dose_or_Strength Arg1:T15 Arg2:T40	
R27	Has_Duration_or_Interval Arg1:T16 Arg2:T42	
R28	Has_Duration_or_Interval Arg1:T3 Arg2:T42	
R29	Has_Duration_or_Interval Arg1:T15 Arg2:T42	
R30	Before Arg1:T1 Arg2:T2	
R31	Before Arg1:T9 Arg2:T7	
R32	Experiences Arg1:T44 Arg2:T27	
R33	Experiences Arg1:T44 Arg2:T31	
R34	Experiences Arg1:T44 Arg2:T19	
R35	Before Arg1:T27 Arg2:T31	
R36	Before Arg1:T27 Arg2:T19	
T56	Observation 1037 1058	disminución del dolor
#48	AnnotatorNotes T56	C5230944; Sensation of pain reduced; Finding
R37	Before Arg1:T32 Arg2:T56	
T57	Neg_cue 967 969	no
R38	Negation Arg1:T57 Arg2:T58	
R39	Has_Route_or_Mode Arg1:T20 Arg2:T48	
R40	Has_Drug_Form Arg1:T20 Arg2:T47	
R41	Has_Route_or_Mode Arg1:T20 Arg2:T45	
R42	Before Arg1:T20 Arg2:T56	
R43	Has_Drug_Form Arg1:T23 Arg2:T50	
R46	Before Arg1:T23 Arg2:T24	
R47	Before Arg1:T23 Arg2:T34	
R44	Before Arg1:T3 Arg2:T12	
R45	Before Arg1:T20 Arg2:T32	
T58	CONC 984 994	resultados
A7	Assertion T58 Negated
T59	Quantifier_or_Qualifier 995 1021	descritos por otros grupos
A8	Assertion T59 Negated
R48	Has_Quantifier_or_Qualifier Arg1:T58 Arg2:T59	
T60	Quantifier_or_Qualifier 1142 1156	significativas
#49	AnnotatorNotes T60	C0750502; Significant; Idea or Concept
R49	Has_Quantifier_or_Qualifier Arg1:T54 Arg2:T60	
A9	Assertion T60 Negated
R50	Negation Arg1:T55 Arg2:T60	
#50	AnnotatorNotes T58	C1274040; Result; Functional Concept
A10	Experiencer T38 Patient
A11	Experiencer T44 Patient
